BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 35156588)

  • 1. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
    K W To K; Cho WCS
    Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing-an emerging strategy in cancer therapeutics.
    Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 4. Can Drug Repurposing Accelerate Precision Oncology?
    Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
    Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
    Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
    Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing for cancer therapy.
    Xia Y; Sun M; Huang H; Jin WL
    Signal Transduct Target Ther; 2024 Apr; 9(1):92. PubMed ID: 38637540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment.
    Kenmogne VL; Nweke EE; Takundwa MM; Fru PN; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2023; 1410():115-126. PubMed ID: 36289161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
    Weth FR; Hoggarth GB; Weth AF; Paterson E; White MPJ; Tan ST; Peng L; Gray C
    Br J Cancer; 2024 Mar; 130(5):703-715. PubMed ID: 38012383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
    Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
    Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence in Cancer Research and Precision Medicine.
    Bhinder B; Gilvary C; Madhukar NS; Elemento O
    Cancer Discov; 2021 Apr; 11(4):900-915. PubMed ID: 33811123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases.
    Walpole IR; Zaman FY; Zhao P; Marshall VM; Lin FP; Thomas DM; Shackleton M; Antolin AA; Ameratunga M
    Clin Transl Med; 2024 Apr; 14(4):e1657. PubMed ID: 38629623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug rechanneling: A novel paradigm for cancer treatment.
    Kaushik I; Ramachandran S; Prasad S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
    Shah RR; Stonier PD
    J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.